- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT00091702
Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents
A Phase I/II Randomized Trial of the Safety and Immunogenicity of Cold Adapted Influenza Vaccine (FluMist) in HIV-Infected Children and Adolescents
Visão geral do estudo
Status
Condições
Descrição detalhada
Influenza virus infections are common among children, particularly during the winter season. The infections are often mild, but more serious cases can cause a number of complications, including respiratory illnesses and bacterial infections. HIV infected children may have an increased risk for developing influenza-related bacterial complications, and influenza infections among this population may lead to more rapid disease progression. The current standard of care for HIV infected children is vaccination with an inactivated influenza vaccine (IAIV). However, IAIV is limited in its ability to stimulate the immune systems of HIV infected children with advanced disease. FluMist, a cold-adapted live attenuated influenza vaccine, is both immunogenic and effective in HIV infected children; unfortunately, FluMist is associated with viral shedding, a period of time when the influenza virus used to produce the vaccine may be transmitted to other people. This study will compare the safety and immunogenicity of IAIV and FluMist in HIV infected children and adolescents. This study will also determine the prevalence and duration of FluMist viral shedding in HIV infected children and adolescents who have received the vaccination.
Participants in this study will be randomly assigned to one of two arms. Arm A participants will receive FluMist; Arm B participants will receive IAIV. A single immunization will occur on Day 0 of the study. Arm A participants will have study visits on Days 3, 14, and 28 or home visits on Days 3 and 14. Participants in Arm B will have a study visit on Day 28. A physical exam will be performed at the initial study visit; blood will be collected at study start and at each visit thereafter. Phone calls will be made to participants throughout the study. All participants will have a final study visit after 6 months.
Tipo de estudo
Inscrição
Estágio
- Fase 2
- Fase 1
Contactos e Locais
Locais de estudo
-
-
Alabama
-
Birmingham, Alabama, Estados Unidos, 35233
- UAB, Dept. of Ped., Div. of Infectious Diseases
-
Mobile, Alabama, Estados Unidos
- Univ. of South Alabama College of Medicine, Southeast Ped. ACTU
-
-
Arizona
-
Phoenix, Arizona, Estados Unidos, 85006
- Phoenix Children's Hosp.
-
-
California
-
Long Beach, California, Estados Unidos, 90801
- Long Beach Memorial Med. Ctr., Miller Children's Hosp.
-
Los Angeles, California, Estados Unidos, 90033
- Usc La Nichd Crs
-
Los Angeles, California, Estados Unidos
- UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS
-
Oakland, California, Estados Unidos, 94609-1809
- Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab.
-
Orange, California, Estados Unidos, 92868
- Children's Hosp. of Orange County
-
San Diego, California, Estados Unidos, 92103
- UCSD Maternal, Child, and Adolescent HIV CRS
-
San Francisco, California, Estados Unidos, 94143-0105
- UCSF Pediatric AIDS CRS
-
Torrance, California, Estados Unidos, 90509
- Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases
-
-
Colorado
-
Aurora, Colorado, Estados Unidos
- Univ. of Colorado Denver NICHD CRS
-
-
Connecticut
-
Hartford, Connecticut, Estados Unidos
- Connecticut Children's Med. Ctr.
-
New Haven, Connecticut, Estados Unidos, 06504
- Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease
-
-
District of Columbia
-
Washington, District of Columbia, Estados Unidos, 20010
- Children's National Med. Ctr., ACTU
-
Washington, District of Columbia, Estados Unidos, 20060
- Howard Univ. Washington DC NICHD CRS
-
Washington, District of Columbia, Estados Unidos, 20010
- Children's National Med. Ctr. Washington DC NICHD CRS
-
-
Florida
-
Fort Lauderdale, Florida, Estados Unidos, 33316
- South Florida CDC Ft Lauderdale NICHD CRS
-
Fort Lauderdale, Florida, Estados Unidos
- Children's Diagnostic & Treatment Ctr. of South Florida
-
Gainesville, Florida, Estados Unidos, 32610-0296
- Univ. of Florida College of Medicine-Dept of Peds, Div. of Immunology, Infectious Diseases & Allergy
-
Jacksonville, Florida, Estados Unidos, 32209
- Univ. of Florida Jacksonville NICHD CRS
-
Miami, Florida, Estados Unidos, 33136
- Univ. of Miami Ped. Perinatal HIV/AIDS CRS
-
Tampa, Florida, Estados Unidos, 33620
- USF - Tampa NICHD CRS
-
-
Georgia
-
Augusta, Georgia, Estados Unidos
- Med. College of Georgia School of Medicine, Dept. of Peds., Div. of Infectious Diseases
-
Columbus, Georgia, Estados Unidos, 31901
- Columbus Regional HealthCare System, The Med. Ctr.
-
-
Illinois
-
Chicago, Illinois, Estados Unidos, 60614
- Chicago Children's CRS
-
Chicago, Illinois, Estados Unidos
- Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease
-
Chicago, Illinois, Estados Unidos
- Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program
-
-
Louisiana
-
New Orleans, Louisiana, Estados Unidos, 70112-2699
- Tulane/LSU Maternal/Child CRS
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos
- Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases
-
Baltimore, Maryland, Estados Unidos
- Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02115
- HMS - Children's Hosp. Boston, Div. of Infectious Diseases
-
Boston, Massachusetts, Estados Unidos, 02118
- BMC, Div. of Ped Infectious Diseases
-
Lawrence, Massachusetts, Estados Unidos, 01841-2884
- Lawrence Family Health Ctr., Essex St. Clinic
-
Lowell, Massachusetts, Estados Unidos, 01854
- Lowell Community Health Ctr.
-
Springfield, Massachusetts, Estados Unidos, 01199
- Baystate Health, Baystate Med. Ctr.
-
Worcester, Massachusetts, Estados Unidos
- WNE Maternal Pediatric Adolescent AIDS CRS
-
-
Michigan
-
Detroit, Michigan, Estados Unidos, 48201
- Children's Hospital of Michigan NICHD CRS
-
-
Missouri
-
Saint Louis, Missouri, Estados Unidos, 63110
- Washington Univ. School of Medicine at St. Louis, St. Louis Children's Hosp.
-
-
New Jersey
-
Newark, New Jersey, Estados Unidos
- NJ Med. School CRS
-
-
New York
-
Bronx, New York, Estados Unidos, 10457
- Bronx-Lebanon Hosp. IMPAACT CRS
-
Bronx, New York, Estados Unidos, 10461
- Jacobi Med. Ctr. Bronx NICHD CRS
-
Bronx, New York, Estados Unidos, 10461
- Jacobi Med. Ctr.
-
Brooklyn, New York, Estados Unidos, 11203-2098
- SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS
-
New York, New York, Estados Unidos, 10016
- Nyu Ny Nichd Crs
-
New York, New York, Estados Unidos, 10037
- Harlem Hosp. Ctr. NY NICHD CRS
-
New York, New York, Estados Unidos
- Columbia IMPAACT CRS
-
New York, New York, Estados Unidos, 10029
- Mt. Sinai School of Medicine, Div. of Ped. Infectious Diseases
-
Rochester, New York, Estados Unidos, 14642
- Strong Memorial Hospital Rochester NY NICHD CRS
-
Stony Brook, New York, Estados Unidos, 11794-8111
- SUNY Stony Brook NICHD CRS
-
Syracuse, New York, Estados Unidos, 13210
- SUNY Upstate Med. Univ., Dept. of Peds.
-
-
North Carolina
-
Chapel Hill, North Carolina, Estados Unidos, 27599-7220
- UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases
-
Durham, North Carolina, Estados Unidos, 27705
- DUMC Ped. CRS
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Estados Unidos, 19104-4318
- The Children's Hosp. of Philadelphia IMPAACT CRS
-
-
Tennessee
-
Memphis, Tennessee, Estados Unidos, 38105-2794
- St. Jude/UTHSC CRS
-
-
Texas
-
Houston, Texas, Estados Unidos, 77030
- Texas Children's Hosp. CRS
-
-
Virginia
-
Norfolk, Virginia, Estados Unidos, 23507
- Children's Hosp. of the King's Daughters, Infectious Disease
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98105
- UW School of Medicine - CHRMC
-
Seattle, Washington, Estados Unidos, 98105-0371
- Seattle Children's Hospital CRS
-
-
-
-
-
San Juan, Porto Rico
- San Juan City Hosp. PR NICHD CRS
-
San Juan, Porto Rico, 00936-5067
- Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- HIV infected
- Stable highly active antiretroviral therapy (HAART) regimen for at least 16 weeks with no changes in therapy anticipated
- Meet certain CD4 cell count and CD4% requirements
- Viral load of less than 60,000 copies/ml within 60 days prior to study start
- Received inactivated influenza vaccine (IAIV) in at least one of the past 2 years
- Written informed consent of parent or legal guardian
- Availability of parent or legal guardian to be contacted by phone
Exclusion Criteria:
- Immunosuppressive or immunomodulatory therapy within 60 days prior to immunization or immunological testing
- Aspirin or aspirin-containing therapy at the time of vaccination or planned within 42 days after immunization
- History of hypersensitivity to any component of IAIV or FluMist
- History of Guillain-Barre syndrome
- Receipt of any inactivated vaccine within 14 days prior to the study vaccination
- Receipt of any live vaccine within 30 days prior to the study vaccination
- Plans to receive any vaccine within the 30 days following the vaccination
- Receipt of any additional influenza vaccine for the duration of the study
- Prophylactic use of drugs with anti-influenza activity
- Moderate chronic pulmonary disease, obstructive or restrictive
- Cardiopulmonary disease affecting normal childhood activity
- Medically-diagnosed wheezing, bronchodilator use, or steroid use within the past 42 days
- Medical illness associated with suppression of T-cell immunity
- Pregnancy, breast-feeding, or unwillingness to use acceptable methods of contraception for 3 months following vaccination
- Severely immunosuppressed household member
- Receipt of any blood products within 3 months prior to vaccination or expected receipt during the study, including the 6-month follow-up period
- Significant fever or illness within 72 hours prior to vaccination
- Any other condition that would interfere with the study
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
Colaboradores e Investigadores
Colaboradores
Investigadores
- Cadeira de estudo: Myron J. Levin, MD, University of Colorado, Denver
Publicações e links úteis
Publicações Gerais
- Gunthard HF, Wong JK, Spina CA, Ignacio C, Kwok S, Christopherson C, Hwang J, Haubrich R, Havlir D, Richman DD. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. J Infect Dis. 2000 Feb;181(2):522-31. doi: 10.1086/315260.
- Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 1998 May 14;338(20):1405-12. doi: 10.1056/NEJM199805143382002.
- King JC Jr, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M; HIV Influenza Study Group. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. Pediatr Infect Dis J. 2001 Dec;20(12):1124-31. doi: 10.1097/00006454-200112000-00006.
- King JC Jr, Treanor J, Fast PE, Wolff M, Yan L, Iacuzio D, Readmond B, O'Brien D, Mallon K, Highsmith WE, Lambert JS, Belshe RB. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. J Infect Dis. 2000 Feb;181(2):725-8. doi: 10.1086/315246.
- Weinberg A, Song LY, Walker R, Allende M, Fenton T, Patterson-Bartlett J, Nachman S, Kemble G, Yi TT, Defechereux P, Wara D, Read JS, Levin M; IMPAACT P1057 Team. Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children. J Acquir Immune Defic Syndr. 2010 Oct;55(2):189-96. doi: 10.1097/QAI.0b013e3181e46308.
Datas de registro do estudo
Datas Principais do Estudo
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- P1057
- 10612 (Outro identificador: CTEP)
- PACTG P1057
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Infecções por HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecrutamentoHIV | Teste de HIV | Ligação do HIV ao Cuidado | Tratamento de HIVEstados Unidos
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement e outros colaboradoresDesconhecidoHIV | Crianças não infectadas pelo HIV | Crianças expostas ao HIVCamarões
-
University of MinnesotaRetiradoInfecções por HIV | HIV/AIDS | HIV | AUXILIA | Aids/problema de HIV | AIDS e InfecçõesEstados Unidos
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationConcluídoTeste de HIV do parceiro | Aconselhamento de casal HIV | Comunicação de casal | Incidência de HIVCamarões, República Dominicana, Geórgia, Índia
-
Erasmus Medical CenterAinda não está recrutandoInfecções por HIV | HIV | Infecção por HIV-1 | Infecção HIV IHolanda
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... e outros colaboradoresRecrutamentoHIV | Teste de HIV | Vinculação ao cuidadoÁfrica do Sul
-
National Taiwan UniversityRecrutamento
-
University of Maryland, BaltimoreRetiradoHIV | Transplante de rim | Reservatório de HIV | CCR5Estados Unidos
-
Helios SaludViiV HealthcareDesconhecidoHIV | Infecção por HIV-1Argentina
-
Hospital Clinic of BarcelonaConcluídoInibidores da Integrase, HIV; INIBIDORES DA PROTEASE DO HIVEspanha